Literature DB >> 8580483

The inhibitory effect of astragalus membranaceus on coxsackie B-3 virus RNA replication.

T Peng1, Y Yang, H Riesemann, R Kandolf.   

Abstract

Using mice infected with coxsackie B-3 virus (CVB3) as a viral myocarditis model, we observed the inhibitory effect of Astragalus membranaceus (AM) on CVB3-RNA replication in myocardial tissue of mice by RNA-RNA in situ hybridization with negative-strand RNA probes labelled with 35S and quantitative imaging analysis of positive signals. The mechanism of its effect on CVB3-RNA replication has been investigated by detection of beta-interferon (beta-IFN) as well. Results showed that the copy numbers of CVB3-RNA as well as the histologic scores (necrosis) in myocardial tissues of infected-AM treated mice were significantly lower than those in infected and normal saline treated mice, suggesting that AM could inhibit the replication of CVB3-RNA, but its effect on CVB3-RNA replication had no correlation with induction of beta-IFN.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8580483

Source DB:  PubMed          Journal:  Chin Med Sci J        ISSN: 1001-9294


  5 in total

1.  Total Flavonoids of Astragalus Plays a Cardioprotective Role in Viral Myocarditis.

Authors:  Xiaomin Zhou; Qing Xin; Yilin Wang; Yajun Zhao; Hua Chai; Xia Huang; Xiexin Tao; Ming Zhao
Journal:  Acta Cardiol Sin       Date:  2016-01       Impact factor: 2.672

2.  Astragalus in the prevention of upper respiratory tract infection in children with nephrotic syndrome: evidence-based clinical practice.

Authors:  Chuan Zou; Guobin Su; Yuchi Wu; Fuhua Lu; Wei Mao; Xusheng Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-09       Impact factor: 2.629

3.  Regulation of inflammatory gene expression in PBMCs by immunostimulatory botanicals.

Authors:  Karen L Denzler; Robert Waters; Bertram L Jacobs; Yvan Rochon; Jeffrey O Langland
Journal:  PLoS One       Date:  2010-09-03       Impact factor: 3.240

Review 4.  Herbal plants and plant preparations as remedial approach for viral diseases.

Authors:  Rajesh Kumar Ganjhu; Piya Paul Mudgal; Hindol Maity; Deepu Dowarha; Santhosha Devadiga; Snehlata Nag; Govindakarnavar Arunkumar
Journal:  Virusdisease       Date:  2015-09-03

5.  Characterization of the Physiological Response following In Vivo Administration of Astragalus membranaceus.

Authors:  Karen Denzler; Jessica Moore; Heather Harrington; Kira Morrill; Trung Huynh; Bertram Jacobs; Robert Waters; Jeffrey Langland
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-12       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.